Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy

Detalles Bibliográficos
Autores principales: Lorenzo, Giuseppe Di, Scafuri, Luca, Costabile, Ferdinando, Pepe, Liuba, Scognamiglio, Anna, Crocetto, Felice, Guerra, Germano, Buonerba, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890115/
https://www.ncbi.nlm.nih.gov/pubmed/35251698
http://dx.doi.org/10.2144/fsoa-2022-0002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890115/
https://www.ncbi.nlm.nih.gov/pubmed/35251698
http://dx.doi.org/10.2144/fsoa-2022-0002

Ejemplares similares